Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Regenxbio (NASDAQ: RGNX ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Regenxbio reported strong prog
The clinical-stage biotech said H1 2026 revenue fell to €1.1 million from €2.4 million a year earlier. It also said cash and cash equivalents were €17.1 million at June 30 and runway was estimated to December 2026.
Commercial Metals reports 78.6% year-over-year increase in core EBITDA to $353.6 million, with a core EBITDA margin increase to 14.2%.
CMC reports its third quarter fiscal 2026 results.